Sorafenib Tosylate CAS 475207-59-1

Product Description:

Product Name: Sorafenib tosylate CAS NO: 475207-59-1

Synonyms:

Bay 43-9006;

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide,4-methylbenzenesulfonic acid;

Nexavar;

Chemical & Physical Properties:

Appearance: White to off-white crystalline powder

Assay :≥99.00%

Density: 1.454 g/cm3

Boiling Point: 523.3℃ at 760 mmHg

Flash Point: 270.3℃

Safety Information:

Risk Statements: R36/37/38

Safety Statements: S28-26

HS Code: 29159000

Sorafenibtosylate, chemically known as 4-{4- [({[4-chloro-3 -(trifluoromethyl) phenyl] amino} carbonyl) amino] phenoxy} -N-methylpyridine-2-formamide p-toluene sulfonate, trade name Nexavar, It was first developed by Chemicalbook Ear Pharmaceutical Company in Germany. Sorafenib p-toluenesulfonate is a multi-kinase inhibitor that can be used to treat diseases such as cancer. In December 2005, it was approved by FDA in the United States for the first time as a first-line drug for the treatment of advanced renal cancer. In August 2009, it was officially approved by the State Food and Drug Administration for the first time in China.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.